Last updateThu, 23 Mar 2023 12pm

Stratasys Signs Agreement with Ricoh USA, Inc. for Print-On-Demand Medical Models

Collaboration increases access to 3D-printed anatomic models for hospitals and clinics.

Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing, announced today it has signed an agreement with Ricoh USA, Inc. to provide on-demand 3D-printed anatomic models for clinical settings.

CHU de Brest improves surgical planning with new Stratasys 3D printing technology for patient-specific anatomic models

J5 MediJet 3D printer’s multi-material, multi-color capabilities enable surgeons to produce realistic models to plan complex surgical procedures, improving planning, training and patient outcomes

France-based Regional University Hospital of Brest (CHU de Brest) is witnessing substantial improvements in pre-surgical planning procedures following the implementation of a new 3D printer by Stratasys’ partner-reseller, Cylaos.

Acetabular Revision Using a Patient-Specific Hip Implant

In this video, Dr. Gijs van Hellemondt and Dr. Maarten Spruit from the Sint-MaartensKliniek in Nijmegen perform hip revision surgery on a 60-year-old rheumatoid patient who has had several surgeries on both sides. The surgeons used the personalized Materialise aMace implant system for this complex revision case.

Software Developers, Sailors, and Surgeons Collaborating in the 20+ Years of OrthoView

Former operation planningOver 20 years ago, OrthoView formed under a collaborative spirit that has survived to this day. With this attitude, they have developed innovative features driven by surgeons' need for joint replacements, trauma, and spine procedures. In this blog, we'll go over a few formative moments in the development of OrthoView.

HP Multi Jet Fusion technology helps Brinter launch its innovative bioprinting solutions faster and more affordably

Brinter® Bioprinting Solutions include over 60 3D-printed parts using HP Multi Jet Fusion technology, making up 75% of all the custom-made medical equipment 3D parts found in the machine.


Brinter®, a trailblazing Finnish bioprinting company, provides comprehensive 3D bioprinting solutions and services for the MedTech industry.

3D Printing of Industrial, Pharmaceutical and Other Materials Using Granulate Printing (GP) Process

Figure 1. The Granu Tool print head in action (left) and cellulose-based granules used in the 3D printing process (right).Brinter has been developing the granulate-based multi-material 3D printing process as part of the EU Horizon2020 project Novum. The increased concern of environmental issues and technology development has led to growing interest in developing novel, sustainable, yet high-performance materials for industrial additive manufacturing (AM) and for a wide variety of applications such as electrical insulation components and parts for the automotive, marine and medical industry. AM enables rapid and cost-effective manufacturing of complex and lightweight parts without any expensive tools such as moulds.

Traditional model-makers propel medical education forward using the Mimaki 3DUJ series

Andreas Falk, COO of Erler Zimmer, an expert company in anatomical model-making, discusses the use of 3D printing and how it has helped revolutionise their industry.

Historically, the use of cadavers has been paramount in the effective teaching of anatomical science and medicine. How better to understand anatomy than to dissect and examine that of a real body, however, in recent years it has become apparent that 3D printing holds the potential to revolutionize medical education.

New 3D-Printing Material and Fastest High Precision Printer Create Human Body-Like Micro-Environment

Fast & reliable production of cell-culture device for IVF with new material and NanoOne-printer

A novel material for 2PP 3D-printing will contribute to a game changing innovation in the in vitro fertilization (IVF) market. UpFlow, a photopolymerizing material developed by UpNano GmbH (Austria), allows the fast and precise 3D-printing of micro-environments for a novel type of dynamic cell culture.

Carbon's biodegradable elastomer platform has proven its biocompatibility in vivo

Carbon, a leader in 3D printing technology, today announced that its platform for bioresorbable elastomers, currently in development, has proven its biocompatibility in vivo[1]. All samples were found to be non-toxic and have a controllable absorption time. This latest milestone demonstrates the potential of the elastomer for the development of biomedical mesh applications such as soft tissue repair, wound dressings and nerve conduits.

AM Medical Days 2022

3D printing in medical - providing better patient outcomes
The hybrid conference for decision-makers and experts brings together the entire value-added system attracted to 3D-printed medical devices. Doctors, hospital representatives, medical technology manufacturers, licensing authorities, and health insurances will have the opportunity to connect with leading software providers, material suppliers, printer manufacturers, and service providers to discuss the question: How to advance additive technologies to succed in its medical application. At the two-day conference, we expect 42 exhibitors and sponsors, 280 attendees, and 40 speakers.

More Articles ...

  • Latest Post

  • Most Read

  • Twitter

Who's Online

We have 6035 guests and no members online

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.